UCB Pharma (Portugal)

Homepage: ucb.com

Parent institution: UCB Pharma (Belgium)

ROR: 04a73z253

OpenAlex ID: I4405256563

Long-term compliance, safety, and tolerability of sodium oxybate treatment in patients with narcolepsy type 1: a postauthorization, noninterventional surveillance study

2018 · Geert Mayer, Giuseppe Plazzi, et al. · SLEEP · 47

Evaluation of the Effectiveness of the Risk Minimization Measures of Sodium Oxybate in the European Union

2020 · Alex Iranzo, Pedro Serralheiro, et al. · Drugs - Real World Outcomes · 3

Works count: 2

Citation count: 50